COVID-19 morbidity and severity in patients with age-related macular degeneration: a Korean nationwide cohort study
Coronavirus disease 2019 (COVID-19) resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global emergency.1 Recent studies on factors that increase susceptibility to COVID-19 or worsen clinical outcomes of this disease have focused on common diseases and conditions such as cardiopulmonary disorders, cancer, and diabetes mellitus.2, 3 Although little attention has been paid to extrapulmonary comorbidities, associations between chronic central nervous system comorbidity and COVID-19 outcomes have been reported.
Source: American Journal of Ophthalmology - Category: Opthalmology Authors: Jee Myung Yang, Sung Yong Moon, Joo Young Lee, Dritan Agalliu, Dong Keon Yon, Seung Won Lee Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Cancer | Cancer & Oncology | Cardiology | Coronavirus | COVID-19 | Diabetes | Diabetes Mellitus | Emergency Medicine | Endocrinology | Heart | Opthalmology | Respiratory Medicine | SARS | Study